Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07030348

Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
263 (estimated)
Sponsor
Do Hyun Park · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

Purpose Pancreatic cancer is the fourth leading cancer-related mortality disease in the United States, with a five-year survival rate of 11%, and only 10 15% of all pancreatic cancer patients are operable or borderline operable. Therefore, there is an unmet need for early diagnosis of pancreatic cancer; however, biomarkers related to this are not well understood. This study aims to identify biomarkers for the early diagnosis of pancreatic cancer through duodenal pancreatic juice, which can be easily obtained through an endoscopy.

Detailed description

Pancreatic cancer is the fourth leading cancer-related mortality disease in the United States, with a five-year survival rate of 11%, which is a very poor prognosis, and only 10-15% of all pancreatic cancer patients are operable or borderline operable. Therefore, there is an unmet need for early diagnosis of pancreatic cancer; however, the biomarkers of humoral fluids associated with the early diagnosis of pancreatic cancer are not well understood. Duodenal pancreatic fluids can be easily obtained through an endoscopy and contain a large amount of pancreatic fluid secreted by the pancreas, which is known to be a candidate of biomarkers for early diagnosis of pancreatic cancer. However, there have been few studies using duodenal fluids in Korea. This study aims to prospectively analyze biomarkers for early diagnosis of pancreatic cancer using duodenal fluids obtained by endoscopy in pancreatic and non-pancreatic cancer groups.

Conditions

Timeline

Start date
2024-01-02
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-06-22
Last updated
2025-06-22

Locations

3 sites across 2 countries: United States, South Korea

Source: ClinicalTrials.gov record NCT07030348. Inclusion in this directory is not an endorsement.